Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-05-28 Purchase | 2024-05-30 4:35 pm | NEPHROS INC | NEPH | Amron Arthur H Director | 5,000 | $2.2352 | $11,176 | 110,786 (Direct) | View |
2024-05-16 Purchase | 2024-05-16 4:49 pm | NEPHROS INC | NEPH | Banks Robert R. Jr. President and CEO | 50,000 | $2.241 | $112,050 | 437,571 (Direct) | View |
2024-03-12 Purchase | 2024-03-14 4:28 pm | NEPHROS INC | NEPH | Amron Arthur H Director | 7,000 | $2.4471 | $17,130 | 189,926 (Direct) | View |
2023-12-07 Purchase | 2023-12-11 4:17 pm | NEPHROS INC | NEPH | Banks Robert R. Jr. President and CEO | 18,000 | $2.2026 | $39,647 | 377,165 (Direct) | View |
2023-08-14 Purchase | 2023-08-15 4:15 pm | NEPHROS INC | NEPH | Banks Robert R. Jr. President and CEO | 2,000 | $1.6776 | $3,355 | 359,165 (Direct) | View |
2021-08-20 Purchase | 2021-08-23 1:01 pm | NEPHROS INC | NEPH | Lobo Wesley S. Chief Marketing Officer | 1,000 | $7.92 | $7,920 | 155,735 (Direct) | View |
2021-08-18 Purchase | 2021-08-19 9:04 pm | NEPHROS INC | NEPH | Gwydir Tom Director | 5,000 | $7.64 | $38,200 | 33,076 (Direct) | View |
2021-08-17 Purchase | 2021-08-18 6:08 pm | NEPHROS INC | NEPH | Astor Andrew President & CEO | 5,000 | $7.721 | $38,605 | 403,540 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-14 Option Award | 2024-05-16 4:49 pm | N/A 2034-05-14 | NEPHROS INC | NEPH | Banks Robert R. Jr. President and CEO | 10,406 | $0 | 437,571 (Direct) | View |
2024-05-14 Option Award | 2024-05-16 4:29 pm | N/A 2034-05-14 | NEPHROS INC | NEPH | Amron Arthur H Director | 7,323 | $0 | 105,786 (Direct) | View |
2024-05-14 Option Award | 2024-05-16 4:26 pm | N/A 2034-05-14 | NEPHROS INC | NEPH | Lask Alisa Director | 7,323 | $0 | 92,129 (Direct) | View |
2024-05-14 Option Award | 2024-05-16 4:25 pm | N/A 2034-05-14 | NEPHROS INC | NEPH | Spandow Oliver J. Director | 7,323 | $0 | 130,114 (Direct) | View |
2024-05-14 Option Award | 2024-05-16 4:23 pm | N/A 2034-05-14 | NEPHROS INC | NEPH | Harris Joseph Michael Director | 7,323 | $0 | 45,211 (Direct) | View |
2024-03-13 Other | 2024-03-14 4:43 pm | N/A N/A | NEPHROS INC | NEPH | WEXFORD CAPITAL LP Wexford GP LLC DAVIDSON CHARLES E JACOBS JOSEPH 10% Owner | 91,463 | $0 | 3,692,015 (Direct) | View |
2024-03-13 Other | 2024-03-14 4:28 pm | N/A N/A | NEPHROS INC | NEPH | Amron Arthur H Director | 91,463 | $0 | 189,926 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 4:48 pm | N/A N/A | NEPHROS INC | NEPH | Spandow Oliver J. Director | 14,294 | $0 | 122,791 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 4:48 pm | N/A N/A | NEPHROS INC | NEPH | Lask Alisa Director | 9,291 | $0 | 84,806 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 4:48 pm | N/A N/A | NEPHROS INC | NEPH | Harris Joseph Michael Director | 9,291 | $0 | 37,888 (Direct) | View |
2023-12-13 Option Award | 2023-12-15 4:47 pm | N/A N/A | NEPHROS INC | NEPH | Amron Arthur H Director | 9,291 | $0 | 9,291 (Direct) | View |
2023-11-01 Option Award | 2023-11-03 4:30 pm | N/A 2033-11-01 | NEPHROS INC | NEPH | Krandel Judy Chief Financial Officer | 122,524 | $0 | 122,524 (Direct) | View |
Ownership | 2023-05-17 4:28 pm | N/A 2033-05-05 | NEPHROS INC | NEPH | Banks Robert R. Jr. President and CEO | 0 | $0 | 357,165 (Direct) | View |
2023-01-05 Option Award | 2023-01-09 4:33 pm | N/A 2033-01-05 | NEPHROS INC | NEPH | Lask Alisa Director | 34,693 | $0 | 75,515 (Direct) | View |
2023-01-05 Option Award | 2023-01-09 4:32 pm | N/A 2032-01-05 | NEPHROS INC | NEPH | Spandow Oliver J. Director | 49,561 | $0 | 108,497 (Direct) | View |
2023-01-05 Option Award | 2023-01-09 4:31 pm | N/A 2023-01-05 | NEPHROS INC | NEPH | Gwydir Tom Director | 34,693 | $0 | 79,413 (Direct) | View |
2023-01-05 Option Award | 2023-01-09 4:31 pm | N/A 2033-01-05 | NEPHROS INC | NEPH | Amron Arthur H Director | 34,693 | $0 | 34,693 (Direct) | View |
2023-01-05 Option Award | 2023-01-09 4:30 pm | N/A 2033-01-05 | NEPHROS INC | NEPH | Harris Joseph Michael Director | 15,482 | $0 | 28,597 (Direct) | View |
2022-09-06 Option Award | 2022-09-08 4:55 pm | N/A 2032-09-06 | NEPHROS INC | NEPH | Harris Joseph Michael Director | 13,115 | $0 | 13,115 (Direct) | View |
2022-03-05 Exercise | 2022-03-07 5:44 pm | 2017-03-17 2022-03-17 | NEPHROS INC | NEPH | Astor Andrew President, CEO & CFO | 14,815 | $0 | 442,152 (Direct) | View |
2022-03-05 Exercise | 2022-03-07 5:44 pm | N/A N/A | NEPHROS INC | NEPH | Astor Andrew President, CEO & CFO | 14,815 | $2.7 | 442,152 (Direct) | View |
2022-02-16 Tax Withholding | 2022-02-18 5:03 pm | N/A N/A | NEPHROS INC | NEPH | Lobo Wesley S. Chief Marketing Officer | 6,389 | $4.8 | 206,714 (Direct) | View |
2021-12-14 Option Award | 2021-12-16 9:17 pm | N/A 2031-12-14 | NEPHROS INC | NEPH | Lask Alisa Director | 11,644 | $0 | 40,822 (Direct) | View |
2021-12-14 Option Award | 2021-12-16 9:17 pm | N/A 2031-12-14 | NEPHROS INC | NEPH | Gwydir Tom Director | 11,644 | $0 | 44,720 (Direct) | View |
2021-12-14 Option Award | 2021-12-16 9:16 pm | N/A 2031-12-14 | NEPHROS INC | NEPH | Spandow Oliver J. Director | 12,491 | $0 | 58,936 (Direct) | View |
2021-12-14 Option Award | 2021-12-16 9:16 pm | N/A 2031-12-14 | NEPHROS INC | NEPH | Amron Arthur H Director | 11,644 | $0 | 11,644 (Direct) | View |
2021-12-14 Option Award | 2021-12-16 9:16 pm | N/A 2031-12-14 | NEPHROS INC | NEPH | Astor Andrew President & CEO | 38,612 | $0 | 442,152 (Direct) | View |
2021-09-01 Option Award | 2021-09-03 4:29 pm | N/A 2031-09-01 | NEPHROS INC | NEPH | Lobo Wesley S. Chief Commercial Officer | 57,368 | $0 | 213,103 (Direct) | View |
2021-06-01 Exercise | 2021-06-03 4:41 pm | 2016-06-03 2021-06-03 | NEPHROS INC | NEPH | WEXFORD CAPITAL LP Wexford GP LLC DAVIDSON CHARLES E JACOBS JOSEPH Director 10% Owner | 66,667 | $2.7 | 3,650,529 (Indirect) | View |
2021-05-27 Tax Withholding(A) | 2021-06-01 5:39 pm | N/A N/A | NEPHROS INC | NEPH | Evans Daron CEO Specialty Renal Products | 349 | $2.7 | 8,669 (Indirect) | View |
2021-05-24 Exercise | 2021-05-25 3:40 pm | 2016-06-03 2021-06-03 | NEPHROS INC | NEPH | Evans Daron CEO of Specialty Renal Product | 2,222 | $0 | 524,458 (Indirect) | View |
2021-05-24 Exercise | 2021-05-25 3:40 pm | N/A N/A | NEPHROS INC | NEPH | Evans Daron CEO of Specialty Renal Product | 1,111 | $2.7 | 524,458 (Indirect) | View |
2021-02-16 Option Award | 2021-02-18 5:48 pm | N/A 2031-02-16 | NEPHROS INC | NEPH | Lobo Wesley S. Chief Marketing Officer | 154,735 | $0 | 154,735 (Direct) | View |